# A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

> **NCT04657068** · PHASE1,PHASE2 · RECRUITING · sponsor: **Artios Pharma Ltd** · enrollment: 442 (estimated)

## Conditions studied

- Advanced Cancer
- Metastatic Cancer
- Ovarian Cancer
- Primary Peritoneal Cancer
- Fallopian Tube Cancer
- Endometrial Cancer
- Metastatic Colorectal Cancer
- Pancreatic Ductal Adenocarcinoma
- Acinar Cell Carcinoma

## Interventions

- **DRUG:** ART0380
- **DRUG:** Gemcitabine
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT04657068
- **Lead sponsor:** Artios Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-27
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 442 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04657068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04657068, "A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04657068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*